【肺癌】《bioAffinity: BIAF》利用自動流式細胞儀和ML，透過「痰液」識別早期「肺癌」

 【肺癌】《bioAffinity: BIAF》利用自動流式細胞儀和ML，透過「痰液」識別早期「肺癌」獲美國專利

 文章出處  

Businesswire 

 

 原文標題  

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer 

 

 Twitter  

https://x.com/aimedadviser/status/1979537025641619841 

 

 文章序號  

9707 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.